IRIS
GIOVATI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.408
AS - Asia 2.244
EU - Europa 1.979
SA - Sud America 334
AF - Africa 141
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.347
SG - Singapore 894
CN - Cina 751
IT - Italia 475
IE - Irlanda 311
BR - Brasile 274
SE - Svezia 248
DE - Germania 245
FI - Finlandia 217
HK - Hong Kong 164
VN - Vietnam 132
AT - Austria 93
ZA - Sudafrica 85
NL - Olanda 81
TR - Turchia 76
GB - Regno Unito 74
UA - Ucraina 51
RU - Federazione Russa 50
IN - India 48
CA - Canada 40
JP - Giappone 40
BE - Belgio 29
ID - Indonesia 27
KR - Corea 26
FR - Francia 24
ES - Italia 22
AR - Argentina 16
CZ - Repubblica Ceca 16
EC - Ecuador 15
MX - Messico 13
PK - Pakistan 13
PL - Polonia 13
BD - Bangladesh 12
IQ - Iraq 10
KE - Kenya 9
CO - Colombia 8
LT - Lituania 8
MA - Marocco 8
EG - Egitto 6
HU - Ungheria 6
BJ - Benin 5
CI - Costa d'Avorio 5
IL - Israele 5
JO - Giordania 5
LK - Sri Lanka 5
NG - Nigeria 5
NP - Nepal 5
PE - Perù 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
UY - Uruguay 4
BO - Bolivia 3
DZ - Algeria 3
EU - Europa 3
KZ - Kazakistan 3
LV - Lettonia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
ZW - Zimbabwe 3
CL - Cile 2
CM - Camerun 2
DO - Repubblica Dominicana 2
LU - Lussemburgo 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MK - Macedonia 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
SZ - Regno dello Swaziland 1
TG - Togo 1
Totale 8.110
Salva come PNG Salva come JPEG
Città #
Dallas 591
Ashburn 467
Singapore 453
Chandler 367
Dublin 301
Santa Clara 232
Ann Arbor 213
Parma 193
Beijing 168
Hong Kong 159
Dearborn 120
Boardman 95
Vienna 88
New York 84
Los Angeles 83
Johannesburg 81
Munich 80
Nanjing 72
Shanghai 71
Izmir 59
Princeton 59
Ho Chi Minh City 56
Bremen 55
Jacksonville 55
Hefei 44
Wilmington 43
Shenyang 35
Turku 33
Moscow 30
Helsinki 28
Jinan 28
Milan 28
Brussels 27
Columbus 27
Nanchang 26
Hanoi 24
Seoul 24
São Paulo 23
Buffalo 22
Hebei 22
Woodbridge 22
Des Moines 20
San Mateo 20
Tokyo 19
Denver 18
Atlanta 17
Council Bluffs 17
Jakarta 17
Seattle 17
Changsha 15
Grafing 15
Houston 15
London 15
The Dalles 15
Toronto 14
Brooklyn 13
Chennai 13
Haiphong 13
Kunming 13
Nuremberg 13
Reggio Nell'emilia 13
Tianjin 12
Hangzhou 11
Nakano 11
Rome 11
Fremont 10
Modena 10
Rio de Janeiro 10
Verona 10
Warsaw 10
Düsseldorf 9
Guangzhou 9
Jiaxing 9
Norwalk 9
Phoenix 9
Poplar 9
Pune 9
San Francisco 9
Washington 9
Da Nang 8
Morishita 8
Orem 8
San Jose 8
Belo Horizonte 7
Bengaluru 7
Fairfield 7
Frankfurt am Main 7
Haikou 7
Istanbul 7
Nairobi 7
Redwood City 7
Shaoxing 7
Zhengzhou 7
Bilbao 6
Florence 6
Montreal 6
Neviano degli Arduini 6
Ottawa 6
Porto Alegre 6
Stockholm 6
Totale 5.320
Salva come PNG Salva come JPEG
Nome #
Biological behavior of human gingival fibroblasts and formation of microbial biofilm on 3D-printed dental resin restorations 185
Killer Peptide-Containing Polyelectrolytic Nanocomplexes to Fight Toxoplasma gondii Infection 185
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 185
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 178
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 177
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 176
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 173
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 172
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 170
Antibodies as a source of anti-infective peptides: an update 162
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 159
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 157
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 155
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 153
Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides 151
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 146
Metabolic profiling of Candida albicans 145
Screening of thiosemicarbazones as antimycotic drugs 145
Fungicidal activity of peptides encoded by immunoglobulin genes 144
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 142
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 139
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 135
Antifungal activity of the C-terminal peptide from human serum albumin 134
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 133
Peptides from the inside of the antibodies are active against infectious agents and tumours 131
Antibody peptide based antifungal immunotherapy 130
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 130
Antibody-mediated protective immunity in fungal infections 128
Natural and synthetic peptides with antifungal activity 128
Oral and maxillofacial fungal infections 128
Activity of Synthetic Peptide KP and Its Derivatives against Biofilm-Producing Escherichia coli Strains Resistant to Cephalosporins 127
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 126
Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study 125
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 122
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 117
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 117
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 117
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 116
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 115
Wickerhamomyces yeast killer toxins’ medical applications 115
Chimeric symbionts expressing a Wolbachia protein stimulate mosquito immunity and inhibit filarial parasite development 111
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 110
Mode of action of a killer peptide against Toxoplasma gondii 109
Innate antimicrobial and antiviral activities of antibody peptides 108
In vitro and in vivo anticandidal activity of killer peptide derivatives 107
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 106
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 105
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 105
Metabolic profile of Candida albicans 104
The Variability of the Salivary Antimicrobial Peptide Profile: Impact of Lifestyle 103
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 97
The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action 96
Ogni frammento anticorpale può esplicare attività antinfettiva ed antitumorale. 89
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 89
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 88
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 88
Candidacidal properties of peptides encoded by immunoglobulin genes 88
Vaccination of heifers with anaflatoxin improves the reduction of aflatoxin B₁ carry over in milk of lactating dairy cows 87
Single residue contribution to self-aggregation of a fungicidal immunoglobulin-derived peptide 87
Therapeutic effect of an antibody-derived peptide in a Galleria mellonella model of systemic candidiasis 81
Mimotopi killer sintetici 80
Therapeutic effects of an antibody-derived peptide and its alanine scanning derivatives in a Galleria mellonella model of systemic candidiasis 77
Dissection of the structural features and fungicidal activity of an antibody-derived peptide 77
Screening of a Saccharomyces cerevisiae nonessential gene deletion collection for altered susceptibility to a killer peptide 76
Isolation of a Wickerhamomyces anomalus yeast strain from the sandfly Phlebotomus perniciosus, displaying the killer phenotype 66
Yeast killer toxins technology transfer 65
Potential improvement of cheese safety by vaccination of dairy cows: a focus on Anaflatoxin B1. 63
Totale 8.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021218 0 0 0 0 0 16 32 17 64 19 27 43
2021/2022358 23 5 23 39 24 23 21 33 16 24 19 108
2022/20231.335 132 142 93 119 167 158 7 89 386 5 25 12
2023/2024624 30 47 21 38 56 159 40 51 20 47 53 62
2024/20251.802 37 79 99 148 138 249 59 87 251 167 169 319
2025/20262.549 341 580 589 403 540 96 0 0 0 0 0 0
Totale 8.235